and hypoglycemic activities in type 2 diabetic (T2DM) rats. The present study was designed
to further confirm the hypoglycemic effect of APS and to investigate its possible mechanism
underlying the improvement of insulin resistance in vivo and in vitro. Diet-induced insulin
resistant C57BL/6J mice treated with or without APS (orally, 700mg/kg/d) for 8 weeks were
analyzed and compared. Simultaneously, an insulin resistant C2C12 cell model and an ER …